Back
Aptevo Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
APVO
Aptevo Therapeutics
Last Price:
$1.01
Seasonality Move:
9.33%
7 Day Trial
ALL ACCESS PASS
$
7
How to target income on Weekend Liquidity.
You can Watch it Here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing slight buying pressure.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Sell |
| 20-day SMA: | 1.67 | Sell |
| 50-day SMA: | 2.68 | Sell |
| 200-day SMA: | 8.01 | Sell |
| 8-day EMA: | 1.19 | Sell |
| 20-day EMA: | 1.62 | Sell |
| 50-day EMA: | 2.68 | Sell |
| 200-day EMA: | 81.44 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 33.16 | Sell |
| Chaikin Money Flow: | 51551 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 2.48) | Sell |
| Bollinger Bands (100): | (1.8 - 7.42) | Sell |
Aptevo Therapeutics Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 1.01 while APVO 8-day simple moving average is 1.28, which is a Sell signal.
-
The stock price of APVO is 1.01 while Aptevo Therapeutics 20-day SMA is 1.67, which makes it a Sell.
-
Aptevo Therapeutics 50-day simple moving average is 2.68 while APVO share price is 1.01, making it a Sell technically.
-
APVO stock price is 1.01 and Aptevo Therapeutics 200-day simple moving average is 8.01, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
8
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $1.01. The Score for APVO is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
1.5M
Price in USD:
1.01
Share Volume:
272.1K
Aptevo Therapeutics 52-Week Range
52-Week High:
51.06
52-Week Low:
0.94
Sell
8
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?The Aptevo Therapeutics stock price is 1.01 USD today.
-
Will APVO stock go up or go down?Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aptevo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 1.01 while APVO 8-day exponential moving average is 1.19, which is a Sell signal.
-
The stock price of APVO is 1.01 while Aptevo Therapeutics 20-day EMA is 1.62, which makes it a Sell.
-
Aptevo Therapeutics 50-day exponential moving average is 2.68 while APVO share price is 1.01, making it a Sell technically.
-
APVO stock price is 1.01 and Aptevo Therapeutics 200-day simple moving average is 81.44, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $17.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $70.12 per share, and an increase next year of $1.35 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
-
APVO Moving Average Covergence Divergence (MACD) indicator is -0.5, suggesting Aptevo Therapeutics is a Sell
-
Aptevo Therapeutics Relative Strength Index (RSI) is 33.16, which suggest Aptevo Therapeutics is oversold
-
The Bollinger Bands (25) for Aptevo Therapeutics is (1.18 - 2.48), which suggest Aptevo Therapeutics is a Sell
-
The Bollinger Bands (100) for Aptevo Therapeutics is (1.8 - 7.42), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.